SC
Sandip Chandrakant Shah
About Sandip Chandrakant Shah
Data last updated:
Sandip Chandrakant Shah is a Managing Director at Neuberg Diagnostics Private Limited (since 2023), Nominee Director at Pulse Diagnostics Private Limited (since 2023) and Director at Nasmed Diagnostic Private Limited (since 2022), and holds 10 more current directorships. The companies operate in Healthcare, Education & Learing and Real Estate and Construction. The 7 current companies with reported revenue have a combined latest revenue of ₹965 Cr; the largest is Neuberg Diagnostics Private Limited at ₹853 Cr (FY 2025). Earlier, Sandip Chandrakant Shah was a Partner at Bindish Diagnostic Laboratory Llp Llp (2015–2018) and Designated Partner at Nucleus Diagnosys Llp (2022–2024) and 16 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Neuberg Diagnostics Private Limited U85300TN2017PTC114099 | Managing Director | 14 Jul 2023 | 2017 | ₹853 Cr (FY 2025) | Active |
 Pulse Diagnostics Private Limited U85195TN2001PTC194958 | Nominee Director | 19 Apr 2023 | 2001 | ₹80.71 Cr (FY 2024) | Active |
 Nasmed Diagnostic Private Limited U33209GJ2022PTC129341 | Director | 12 Feb 2022 | 2022 | ₹14.34 Cr (FY 2024) | Active |
 Neuberg Supratech Rajkot Private Limited U73100GJ2018PTC104320 | Director | 20 Sep 2018 | 2018 | ₹8.93 Cr (FY 2025) | Active |
 Neuberg Center For Genomic Medicine Private Limited U85200TN2021PTC144003 | Director | 09 Jun 2021 | 2021 | ₹4.52 Cr (FY 2025) | Active |
| Neuberg Supratech Varanasi Healthcare Private Limited U86905GJ2023PTC139301 | Director | 18 Mar 2023 | 2023 | ₹2.21 Cr (FY 2025) | Active |
| Sandip And Bhavini Research Institute Private Limited U80900GJ2022PTC134547 | Director | 04 Aug 2022 | 2022 | ₹1.18 Cr (FY 2025) | Active |
 Mahajan Imaging Private Limited U86905DL1999PTC101010 | Director | 21 Aug 2026 | 1999 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Partner | 02 Jul 2015 | 2015 | Strike Off | ||
 Nucleus Diagnosys Llp AAF-9057 | Designated Partner | 01 Dec 2022 | 2016 | Active | |
| Aalps Tradelink Llp AAJ-1304 | Partner | 15 Mar 2018 | 2017 | Active | |
| Partner | 01 Feb 2020 | 2019 | Active | ||
| Diapoint Labs Llp AAR-4880 | Designated Partner | 01 Jan 2020 | 2020 | Active | |
| Designated Partner | 07 Oct 2020 | 2020 | Active | ||
| Designated Partner | 01 Jan 2021 | 2020 | Active | ||
| Designated Partner | 01 Aug 2021 | 2021 | Active | ||
| Maxivision Laboratories Private Limited U74900TN2016PTC103853 | Director | 27 Oct 2017 | 2016 | ₹9.5 Lakh (FY 2018) | Amalgamated |
| Supratech Micropath Pathology Private Limited U85195GJ2011PTC065871 | Director | 13 Jun 2011 | 2011 | Strike Off | |
 Neuberg Supratech Reference Laboratories Private Limited U85195TN2013PTC151947 | Director | 29 Oct 2013 | 2013 | ₹359 Cr (FY 2022) | Amalgamated |
 Victoria Mri Centre Private Limited U85195WB2008PTC121775 | Nominee Director | 01 Nov 2023 | 2008 | ₹6.02 Cr (FY 2023) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sandip Chandrakant Shah
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sandip Chandrakant Shah
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sandip Chandrakant Shah
Sandip Chandrakant Shah currently holds 13 directorships: Neuberg Diagnostics Private Limited (Managing Director, since 14 Jul 2023, revenue ₹853 Cr (FY 2025)); Pulse Diagnostics Private Limited (Nominee Director, since 19 Apr 2023, revenue ₹80.71 Cr (FY 2024)); Nasmed Diagnostic Private Limited (Director, since 12 Feb 2022, revenue ₹14.34 Cr (FY 2024)); Neuberg Supratech Rajkot Private Limited (Director, since 20 Sep 2018, revenue ₹8.93 Cr (FY 2025)); Neuberg Center For Genomic Medicine Private Limited (Director, since 09 Jun 2021, revenue ₹4.52 Cr (FY 2025)); and 8 more.
Sandip Chandrakant Shah was first appointed on 13 Jun 2011 as Director at Supratech Micropath Pathology Private Limited. The most recent appointment on record is 21 Aug 2026 at Mahajan Imaging Private Limited.
The 7 current companies of Sandip Chandrakant Shah that report revenue have a combined latest revenue of ₹965 Cr: Neuberg Diagnostics Private Limited ₹853 Cr (FY 2025); Pulse Diagnostics Private Limited ₹80.71 Cr (FY 2024); Nasmed Diagnostic Private Limited ₹14.34 Cr (FY 2024); Neuberg Supratech Rajkot Private Limited ₹8.93 Cr (FY 2025); Neuberg Center For Genomic Medicine Private Limited ₹4.52 Cr (FY 2025); and 2 more.
Sandip Chandrakant Shah held 18 earlier board appointments: Bindish Diagnostic Laboratory Llp Llp (Partner, 02 Jul 2015 to 01 Apr 2018); Nucleus Diagnosys Llp (Designated Partner, 01 Dec 2022 to 26 Feb 2024); Aalps Tradelink Llp (Partner, 15 Mar 2018 to 01 Apr 2018); Neuberg Supratech Amreli Laboratory Llp (Partner, 01 Feb 2020 to 14 Jul 2023); Diapoint Labs Llp (Designated Partner, 01 Jan 2020 to 14 Jul 2023); and 13 more.
The current boards of Sandip Chandrakant Shah's companies include Athmanathan Ganesan (Neuberg Diagnostics Private Limited), Gomathy Babu Sadacharam Kulandaivelu (Neuberg Diagnostics Private Limited), Rahul Dilip Shah (Neuberg Diagnostics Private Limited), Roshini Selvakumar (Neuberg Diagnostics Private Limited), Sujay Ramaprasad (Neuberg Diagnostics Private Limited), Vivek Srinivasan (Neuberg Diagnostics Private Limited), among others.